News
Key milestones
Askleia raises €2.3M in new funding round
This fundraising is part of a dynamic of evolution and more faithfully reflects our vision and ambitions to optimise the extraction of the molecule of interest from its culture medium — a purification step that represents the bulk of biopharmaceutical manufacturing costs. This change also reflects the values we uphold every day. It marks an important milestone in our development, while ensuring total continuity in our activities, our teams and our commitments.
Patent application approved and issued: FR24/10483
A step that demonstrates the consistency of our project and strengthens our intellectual property.
Bpifrance Support: €970K unlocked
The company receives €970K in support from Bpifrance (Deeptech Development Aid), strengthening the project's foundations and accelerating its development.
Jean-François Hilaire appointed as Chairman
This appointment marks a key milestone in our governance, ushering in a new phase of strategic development.
Double recognition: Seal of Excellence and Innovative Start-up status
In 2025, we were awarded the "Seal of Excellence" label by the EIC Accelerator and recognised as a disruptive innovative young company.
Seal of Excellence — EIC Accelerator
This European distinction rewards the quality of the project, its level of innovation and its growth potential.
Patent application filed: FR24/10483
We strengthen our intellectual property portfolio with this new patent filing, confirming the maturity of our work.
Third fundraising round of €1.27M
This operation allows us to intensify the development of our technology and provide stronger support to our R&D teams.
Positive Entrepreneurs Trophy
We win the departmental final, an award recognising committed entrepreneurial initiatives with a meaningful impact.
Patent application filed: FR2305928
We continue to structure our intellectual property with the filing of patent application FR2305928 (WO 2024/256448 A1).
Second fundraising round of €740K
This funding strengthens our development capabilities and supports the acceleration of our R&D work.
Winner of the Grand Défi Biomédicament — IT'SME project
As part of a consortium with the CHU de Nancy and the CRCM, the project receives a €590K grant to develop a continuous flow purification tool.
First fundraising round of €190K
This founding milestone accelerates the development of our Y-series and F-series technologies and helps structure our first activities.
Contact :
Hours: 9 a.m. – 5 p.m., Monday to Friday
Phone: +33 4 42 01 90 59
Address: 510 Avenue de Jouques, Pôle Performance, Building C2, 13400 Aubagne
